Breast Cancer Stage II trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Breast Cancer Stage II trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
  NCT06806930 · Phase: Phase 2 · Ages: 21 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.